THERAPEUTISCHE PEPTIDE

Patent europeic · EP2496596 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2496596
Numer da la dumonda
EP10784830
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
02-11-2010
Publitgà
12-09-2012
Concedì
11-01-2017
Stritgà
30-11-2017
Motiv
Taxa annuala betg pajada
Classas IPC
C07K 5/02 (2006.01)
C07D 237/20 (2006.01)
C07D 279/14 (2006.01)
C07K 7/02 (2006.01)
C07D 295/192 (2006.01)
C07D 295/185 (2006.01)
A61P 31/04 (2006.01)
A61K 38/08 (2006.01)
Prioritad
GB 0919194 02.11.2009
Dumonda PCT
PCT/GB2010/002024 02.11.2010
Publicaziun PCT
WO2011/051692 05.05.2011
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 21-06-2018

    Stritgà, taxa betg pajada

    Published in Swissreg on 21.06.2018

  2. 11-01-2017

    Concedì

    Published in Swissreg on 11.01.2017

Partidas

Possessur

Lytix Biopharma AS

Tromsø Science Park P.O. Box 6447, 9294 Tromsø, NO

Inventur

STRØM, Morten

N-9017 Tromsø, NO

HANSEN, Terkel

N-9016 Tromsø, NO

HAVELKOVA, Martina

N-9017 Tromsø, NO

TØRFOSS, Veronika

NO-84500 Stokmarksnes, NO

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.